Purchase Order 36C24223P0840
Award Date
3/30/23
Potential Completion Date
6/30/23
Potential Value
$149K
Federal Agency
Veterans Integrated Service Network 2
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract to Accredo Health Group, Inc., a subsidiary of Express Scripts, to provide OXERVATE 0.002% OPTH DROPS 1 ML 7'S 7ML 2 PACK, a specialty pharmaceutical product. The $74,694.08 contract has an ultimate completion date of March 31, 2025 and was awarded on January 10, 2023 through the VA's Veterans Integrated Service Network 21 (VISN 21). The contract is not designated as a set-aside. Accredo Health Group,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 (VA-VHA VISN 6) awarded a $149,388 firm fixed price purchase order to Accredo Health Group, Inc. of Bartlett, Tennessee for the delivery of Oxiviate Ophthalmic Solution. As a prime contractor supporting VA-VHA pharmaceutical needs, Accredo will provide the specified eye medication to VA medical facilities in the region under the terms of this one month contract running from August 18th to...
This is a $40,697.68 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the supply of specialty pharmaceutical products, including medications to treat pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders. The contract has an ultimate completion date of March 14, 2025 and is part of the VA's Veterans...
This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
This federal contract award, with the ID VA25917E0551, was issued by the Department of Veterans Affairs (VA) to the prime contractor Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The award consists of 13 firm fixed-price purchase orders totaling $108,039.41, with an ultimate completion date of September 30, 2016. The contract does not have a set-aside designation. Accredo Health Group, Inc. has been a long-standing...
This federal contract award, valued at $80,409.58, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company and subsidiary of Express Scripts. The contract is a firm fixed-price purchase order for the delivery of 9 pharmacy orders across multiple VISN locations, including medications to treat conditions such as pulmonary arterial hypertension, neuropathic lysosomal storage...
This federal contract award to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, was made by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for the delivery of specialty pharmaceutical products. The contract, valued at $138,543.43, is a firm fixed price purchase order without any set-aside designation. Accredo, as the prime contractor, provides specialty medications directly to VA medical centers and facilities across the country to...
The Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The $10,708.63 contract is for the emergency purchase of sodium oxybate, a medication used to treat certain medical conditions. The contract has a completion date of March 28, 2025 and is part of the VA's Veterans Integrated Service Network 12 (VISN 12) program, which...
The U.S. Department of Veterans Affairs (VA) awarded a $43,162 firm fixed-price purchase order to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical Prolastin. This contract is not associated with a set-aside program and has an ultimate completion date of June 30, 2024. Accredo Health Group, Inc., a subsidiary of Express Scripts, is a key distributor of complex and high-value medications, primarily serving the healthcare needs of...